Prescription of antithrombotic medications at discharge in the two study subgroups
| Variable | Anaemia (N=258) | Non-anaemic (N=603) | p Value |
|---|---|---|---|
| Triple therapy | 181 (70.2) | 442 (73.3) | 0.15 |
| DAPT | 58 (22.5) | 100 (16.6) | |
| VKA plus clopidogrel | 15 (5.8) | 51 (8.5) | |
| VKA plus aspirin | 4 (1.6) | 10 (1.7) |
Variables are presented as frequency (percentage).
DAPT, dual antiplatelet therapy; VKA, vitamin K antagonist.